Protia Inc
303360
Company Profile
Business description
Protia Inc is a South Korean company engaged in research and development, manufacturing and sales of in vitro diagnostic medical devices and diagnostic reagents. Their main product is allergy diagnostic products for humans and animals,’ as well as various immunochemical in vitro diagnostic products.
Contact
Room 702, Building A
401 Yangcheon-ro
Gangseo-gu
Seoul07528
KORT: +82 269685277
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
97
Stocks News & Analysis
stocks
Undervalued ASX share with plan to mitigate tariff risk
Shares have dropped 20% in the previous year due to concerns about tariffs.
stocks
Earnings up but shares overvalued for ASX gold miner
Higher gold prices are making a difference to the bottom line but investors overly optimistic.
stocks
Alphabet: Anthropic deal and Gemini momentum stand to deliver; Fair Value up 27%
We see faster cloud growth and improved longer-term profitability for Alphabet.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,295.80 | 26.20 | -0.28% |
| CAC 40 | 8,233.06 | 6.12 | -0.07% |
| DAX 40 | 24,291.82 | 16.96 | -0.07% |
| Dow JONES (US) | 47,544.59 | 337.47 | 0.71% |
| FTSE 100 | 9,667.43 | 13.61 | 0.14% |
| HKSE | 26,346.14 | 87.56 | -0.33% |
| NASDAQ | 23,637.46 | 432.59 | 1.86% |
| Nikkei 225 | 50,219.18 | 293.14 | -0.58% |
| NZX 50 Index | 13,402.66 | 11.07 | 0.08% |
| S&P 500 | 6,875.16 | 83.47 | 1.23% |
| S&P/ASX 200 | 9,012.50 | 16.30 | -0.18% |
| SSE Composite Index | 3,988.22 | 8.72 | -0.22% |